The potential role of immunosuppression, plasmapheresis, and desensitization as treatment modalities for Rh immunization

Michael Caudle, J. R. Scott

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Rh isoimmunization will remain as a clinical problem in some pregnant Rh-negative patients. Technologic advances in fetal and exchange transfusions as well as widespread use of early amniocentesis have considerably improved the overall neonatal survival. At the present time, clinicians should avoid using any immunosuppressive regimen in place of established appropriate management. These experimental regimens pose certain maternal and fetal hazards and have not been shown to decrease fetal morbidity or mortality.

Original languageEnglish (US)
Pages (from-to)313-319
Number of pages7
JournalClinical Obstetrics and Gynecology
Volume25
Issue number2
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Rh Isoimmunization
Intrauterine Blood Transfusion
Amniocentesis
Plasmapheresis
Immunosuppressive Agents
Immunosuppression
Immunization
Mothers
Morbidity
Survival
Mortality
Therapeutics

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

The potential role of immunosuppression, plasmapheresis, and desensitization as treatment modalities for Rh immunization. / Caudle, Michael; Scott, J. R.

In: Clinical Obstetrics and Gynecology, Vol. 25, No. 2, 01.01.1982, p. 313-319.

Research output: Contribution to journalArticle

@article{e57d55dd936d4820bd0730047ca1a5fc,
title = "The potential role of immunosuppression, plasmapheresis, and desensitization as treatment modalities for Rh immunization",
abstract = "Rh isoimmunization will remain as a clinical problem in some pregnant Rh-negative patients. Technologic advances in fetal and exchange transfusions as well as widespread use of early amniocentesis have considerably improved the overall neonatal survival. At the present time, clinicians should avoid using any immunosuppressive regimen in place of established appropriate management. These experimental regimens pose certain maternal and fetal hazards and have not been shown to decrease fetal morbidity or mortality.",
author = "Michael Caudle and Scott, {J. R.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1097/00003081-198206000-00011",
language = "English (US)",
volume = "25",
pages = "313--319",
journal = "Clinical Obstetrics and Gynecology",
issn = "0009-9201",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The potential role of immunosuppression, plasmapheresis, and desensitization as treatment modalities for Rh immunization

AU - Caudle, Michael

AU - Scott, J. R.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Rh isoimmunization will remain as a clinical problem in some pregnant Rh-negative patients. Technologic advances in fetal and exchange transfusions as well as widespread use of early amniocentesis have considerably improved the overall neonatal survival. At the present time, clinicians should avoid using any immunosuppressive regimen in place of established appropriate management. These experimental regimens pose certain maternal and fetal hazards and have not been shown to decrease fetal morbidity or mortality.

AB - Rh isoimmunization will remain as a clinical problem in some pregnant Rh-negative patients. Technologic advances in fetal and exchange transfusions as well as widespread use of early amniocentesis have considerably improved the overall neonatal survival. At the present time, clinicians should avoid using any immunosuppressive regimen in place of established appropriate management. These experimental regimens pose certain maternal and fetal hazards and have not been shown to decrease fetal morbidity or mortality.

UR - http://www.scopus.com/inward/record.url?scp=0020318454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020318454&partnerID=8YFLogxK

U2 - 10.1097/00003081-198206000-00011

DO - 10.1097/00003081-198206000-00011

M3 - Article

VL - 25

SP - 313

EP - 319

JO - Clinical Obstetrics and Gynecology

JF - Clinical Obstetrics and Gynecology

SN - 0009-9201

IS - 2

ER -